Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
filingDate |
1984-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1987-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
1987-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0114048-B1 |
titleOfInvention |
Use of d,l and d-carazolole for the manufacture of antiglaucoma agents and pharmaceutical compositions containing d-carazolole |
abstract |
The present invention is concerned with the topical use of D,L- and D-carazolol and of the pharmacologically acceptable salts in the therapy of glaucoma. The present invention is also concerned with eye drops containing these active materials. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0231444-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0231444-A3 |
priorityDate |
1983-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |